Rx 2018: A New Era of Specialty Drugs, Telehealth, Mobile Apps and Value, IQVIA Reports
Health Populi
MARCH 13, 2018
In 2018, spending on branded prescription drugs will fall in wealthy countries, while spending on specialty drugs will increase, resulting in flat medicines spending. Specifically, $19 billion worth of biotech spending will find biosimilar competition starting in 2018 for the first time. In the U.S.,
Let's personalize your content